Search Results for "Devices"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Devices. Results 111 to 120 of 220 total matches.
Beta-Adrenergic Blockers and Breast Cancer
The Medical Letter on Drugs and Therapeutics • Jan 23, 2012 (Issue 1382)
The Medical Letter’s free App for the iPhone,
iPad and Android through your device’s App store.
BlackBerry ...
Three retrospective studies have recently reported an
association between beta-blocker use and a reduction
in breast cancer metastasis and recurrence. No
prospective, randomized trials have been published.
Drugs for Head Lice
The Medical Letter on Drugs and Therapeutics • Jun 10, 2024 (Issue 1704)
device that kills lice and nits through dehydration.
The device blows heated air along the scalp ...
Pediculosis capitis (head lice infestations) occur in
all age groups, but especially in elementary school
children. In most cases, transmission occurs by
head-to-head contact. Pharmacologic treatment is
recommended for persons with live lice or eggs (nits)
within 1 cm of the scalp. Topical pediculicides should
be tried first. Oral therapy is occasionally required for
refractory infestations.
Med Lett Drugs Ther. 2024 Jun 10;66(1704):89-92 doi:10.58347/tml.2024.1704a | Show Introduction Hide Introduction
Robotic-Assisted Laparoscopic Surgery
The Medical Letter on Drugs and Therapeutics • Jun 14, 2010 (Issue 1340)
the devices say one
limitation is decreased tactile feedback, but with the
ability of robotic arms to pivot ...
The da Vinci Surgical System (Intuitive Surgical, Sunnyvale, CA) has become available in recent years
for use in laparoscopic prostatectomy, gynecological procedures, general surgery, otolaryngology and cardiothoracic procedures.
Anoro Ellipta: An Inhaled Umeclidinium/Vilanterol Combination for COPD
The Medical Letter on Drugs and Therapeutics • Apr 14, 2014 (Issue 1440)
bronchodilators in a single delivery device.
This is the first approved indication for umeclidinium ...
The FDA has approved an inhaled fixed-dose
combination of the long-acting anticholinergic
umeclidinium (ue mek" li din' ee um) and the long-acting
beta2-adrenergic agonist (LABA) vilanterol
(Anoro Ellipta – GSK/Theravance) for once-daily
maintenance treatment of chronic obstructive
pulmonary disease (COPD). Anoro Ellipta is the first
product available in the US that combines two long-acting
bronchodilators in a single delivery device.
Exablate Neuro for Essential Tremor
The Medical Letter on Drugs and Therapeutics • Mar 27, 2017 (Issue 1517)
cannot undergo an MRI scan, such as
those with implanted metallic devices. Pregnancy,
advanced kidney ...
The FDA has approved use of Exablate Neuro (Insightec)
for unilateral thalamotomy to treat medication-refractory
essential tremor in patients ≥22 years old.
Exablate Neuro uses magnetic resonance-guided
focused ultrasound (MRgFUS) to create lesions in the
ventral intermediate nucleus of the thalamus. MRgFUS
is also approved in the US for treatment of uterine
fibroids and for pain palliation of bone metastases.
In Brief: Epinephrine Auto-Injectors for Anaphylaxis (online only)
The Medical Letter on Drugs and Therapeutics • Sep 12, 2016 (Issue 1503)
with the EpiPen
products due to differences in device design and
instructions for use. One pack (two auto ...
News about recent price increases for EpiPen and EpiPen Jr (Mylan) may have patients asking about other options for emergency treatment of anaphylaxis. Adrenaclick and its generic equivalent (epinephrine injection auto-injector) are the only other epinephrine auto-injectors currently available in the US. According to Impax (the manufacturer of both the brand and generic products), Adrenaclick is no longer being manufactured; the generic product will continue to be marketed after supplies of Adrenaclick are depleted. Auvi-Q (Sanofi), an epinephrine auto-injector that was approved by the FDA in...
Ziconotide (Prialt) for Chronic Pain
The Medical Letter on Drugs and Therapeutics • Dec 05, 2005 (Issue 1223)
blocker. It is
intended for use with a programmable implanted
microinfusion device, but an external ...
The FDA has approved ziconotide (Prialt - Elan) intrathecal infusion for management of severe chronic pain in patients who are intolerant of or refractory to other treatments. Ziconotide is a synthetic neuronal N-type calcium channel blocker. It is intended for use with a programmable implanted microinfusion device, but an external microinfusion device can be used temporarily.
In Brief: Femlyv – An Orally Disintegrating Hormonal Contraceptive
The Medical Letter on Drugs and Therapeutics • Dec 09, 2024 (Issue 1717)
in the US
for years.
CHOICE OF CONTRACEPTIVES — Intrauterine devices
(IUDs) and the etonogestrel implant (Nexplanon ...
Femlyv (Millicent), an orally disintegrating tablet
containing ethinyl estradiol and norethindrone
acetate, has been approved by the FDA for prevention
of pregnancy in females with a body mass index (BMI)
≤35 kg/m2. It is the first hormonal contraceptive to
become available in an orally disintegrating tablet
formulation. Traditional oral and chewable tablets
containing ethinyl estradiol and norethindrone acetate
in a wide range of doses, including those found in
Femlyv, have been available in the US for years.
Med Lett Drugs Ther. 2024 Dec 9;66(1717):200 doi:10.58347/tml.2024.1717c | Show Introduction Hide Introduction
Two Neuraminidase Inhibitors for Treatment of Influenza
The Medical Letter on Drugs and Therapeutics • Oct 08, 1999 (Issue 1063)
AND COST — Zanamivir is inhaled through a Diskhaler oral inhalation device similar to those used ...
Zanamivir, a neuraminidase inhibitor taken by inhalation, has been approved by the FDA for treatment of influenza. Oseltamivir phosphate, an oral neuraminidase inhibitor, will probably be approved soon.
Nebulized Budesonide For Asthma in Children
The Medical Letter on Drugs and Therapeutics • Jan 22, 2001 (Issue 1096)
for use in children less than four years old.
INHALATION DELIVERY DEVICES — Inhaled drugs for asthma ...
The FDA has approved a nebulized suspension of the corticosteroid budesonide for maintenance treatment of persistent asthma in children one to eight years old.